ABD-3171

N/A

Report date: 2024/10/31 16:16:48
NME

Base Information

Drug NameABD-3171
Drug Alias NameABD-3171
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldehyde Dehydrogenase 1 Family Member A3 modulators
TargetsAldehyde Dehydrogenase 1 Family Member A3
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungColorectal NeoplasmsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdvanced BioDesign
China Registration ClassN/A

Develop Information

Active CompaniesAdvanced BioDesign
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungColorectal NeoplasmsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A